Opalesque Industry Update, for New Managers - Craig Gordon, MD, a licensed physician with over a decade of buy-side experience managing global biopharmaceutical portfolios, has launched GordonMD Global Investments. The U.S.-based firm is focused on
DocPlanner, a Poland-based operator of a healthcare services booking platform, has completed an undisclosed round at a unicorn valuation (USD 1bn or more), according to two sources familiar with the situation.
KKA Partners has acquired a majority stake in Germany-based mental health care clinic CuraMed Kliniken.
Montagu Private Equity has sold its stake in UK-based healthcare and local authority software developer Servelec to The Access Group, an enterprise software development and consultancy company backed by Hg and TA Associates.
Healthcare and life-sciences-focused venture capital firm Forbion has announced the appointment of Nanna Lüneborg as general partner.
Financial wellness platform Origin has closed its Series B funding round on $56m, which has brought its valuation up to $400m. 01A, General Catalyst and Lachy Groom acted as the lead investors to the Series
Behavioral Health Business (BHB), an Aging Media publication, is excited to announce the inaugural INVEST Conference, a live event where leading experts in private equity, mergers and acquisitions,...(PRWeb August 30, 2021)Read the full story at
Eurazeo has entered into exclusive negotiations to sell its stake in pharmaceutical and specialty ingredients producer Seqens to SK Capital, as well the company’s existing shareholders, which include Ardian.
Cardinal Capital is to acquire specialised children’s residential and therapeutic care provider Ashdale Care, a portfolio company of MML Growth Capital, a source close to the situation confirmed to Unquote.
Bain Capital has sold its stake in Korean cosmetic pharmaceutical company Hugel to a consortium led by CBC Group to give the business a $2.5bn valuation. The post Bain Capital seals $2.5bn Hugel sale to
